ArticleDrug design, development and therapy2014

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.

Andreas O Doesch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.